Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
21.3%
% of BBP's 65 holdings also in IDNA
28.3%
% of IDNA's 51 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
SPRINGWORKS THERAPEUTICS, INC. | 2.1% | 5.0% | 2.1% |
|
EXELIXIS INC | 1.8% | 4.9% | 1.8% |
|
BIOCRYST PHARMACEUTICALS INC | 1.7% | 2.4% | 1.7% |
|
INCYTE CORP | 1.6% | 3.8% | 1.6% |
|
REGENERON PHARMACEUTICALS | 1.6% | 3.9% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to IDNA
|
INTRA-CELLULAR THERAPIES INC | 2.6% |
|
BEIGENE LTD. SPONSORED ADR | 2.3% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.2% |
|
SAGE THERAPEUTICS INC | 2.2% |
|
AXSOME THERAPEUTICS, INC. | 2.1% |
|
GILEAD SCIENCES INC | 2.1% |
|
HALOZYME THERAPEUTICS INC | 2.1% |
|
TG THERAPEUTICS INC | 2.1% |
|
AMGEN INC | 2.0% |
|
BRIDGEBIO PHARMA, INC. | 1.9% |
BBP Underweight Relative to IDNA
|
BEIGENE, LTD. | -6.2% |
 |
ROCHE HOLDING LTD | -5.5% |
 |
SANOFI-AVENTIS | -5.4% |
 |
GSK PLC | -5.3% |
|
ASTRAZENECA PLC | -5.1% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.9% |
 |
GENMAB A/S | -4.3% |
|
MERCK & CO. INC. | -4.1% |
|
ARCELLX, INC. | -3.8% |
|
REVOLUTION MEDICINES, INC. | -3.7% |